Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders-Reference-Cited by-同舟云学术

Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders

Published:2021 Issue:3 Volume:61 Page:120-125
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Kabasawa Nobuyuki¹,Shiozawa Eisuke²,Murai So²,Homma Mayumi²,Uesugi Yuka¹,Matsui Tomoharu¹,Nakata Ayaka¹,Shimada Shotaro¹,Sasaki Yohei¹,Baba Yuta¹,Watanuki Megumi¹,Arai Nana¹,Fujiwara Shun¹,Kawaguchi Yukiko¹,Tsukamoto Hiroyuki¹,Uto Yui¹,Yanagisawa Kouji¹,Hattori Norimichi¹,Sakai Hirotaka³,Harada Hiroshi³,Nakamaki Tsuyoshi¹,Takimoto Masafumi²,Yamochi-Onizuka Toshiko²

Affiliation:

1. Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan,

2. Department of Pathology, Showa University School of Medicine, Tokyo, Japan,

3. Division of Hematology, Department of Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/61/3/61_20025/_pdf

Reference21 articles.

1. 1 Swerdlow SH, Webber SA, Chadobum A, Ferry JA. Post-transplant lymphoproliferative disorders. In : Swerdlow SH, Campo E, Harris NL, et al. (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th ed, Lyon, International Agency for Research on Cancer. 2017; pp. 453-462.

2. 2 Gaulard P, Swerdlow SH, Harris NL, Sundström C, Jaffe ES. Other iatrogenic immunodeficiency associated lymphoproliferative disorders. In : Swerdlow SH, Campo E, Harris NL, et al. (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th ed, Lyon, International Agency for Research on Cancer. 2017; pp. 462-464.

3. 3 Marques-Piubelli ML, Salas YI, Pachas C et al. Epstein–Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Pathology. 2020; 52: 40-52.

4. 4 Ru Y, Chen J, Wu D. Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation. Eur J Haematol. 2018; 101: 283-290.

5. 5 Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013; 8: 173-183.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressants;Reactions Weekly;2022-07